Bristol-Myers Q1 Earnings Beat Driven By Strong Sales

The company posted disappointing sales in international markets, which were more than offset by an increase in revenues in the U.S. International revenues were down 2% to $2 billion. Sales in U.S. markets climbed 16% to $2 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.